207 related articles for article (PubMed ID: 2247493)
1. Cellular maturation and oncogene expression during drug-induced differentiation in vitro: a brief review.
Biedler JL; Spengler BA; Ross RA
Prog Clin Biol Res; 1990; 354A():287-312. PubMed ID: 2247493
[No Abstract] [Full Text] [Related]
2. Carcinogenesis and the response of tumours to anticancer drugs.
Keith WN; Brown R
Anticancer Res; 1991; 11(5):1739-43. PubMed ID: 1768046
[TBL] [Abstract][Full Text] [Related]
3. [Perspectives on modulation of chemoresistance of malignant diseases].
Allerödder HP; Ukena D; Sybrecht GW
Pneumologie; 1993 Sep; 47(9):513-7. PubMed ID: 7901849
[No Abstract] [Full Text] [Related]
4. Role of differentiation induction in tumor suppression.
Marks PA; Rifkind RA
Immunol Ser; 1990; 51():201-16. PubMed ID: 2095918
[No Abstract] [Full Text] [Related]
5. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic inhibition of erb-B2 oncogene expression on a non-small-cell cancer line (NSCLC-N6) by marine substances.
Roussakis C; Charrier J; Riou D; Biard JF; Malochet C; Meflah K; Verbist JF
Anticancer Drug Des; 1994 Apr; 9(2):119-28. PubMed ID: 7909440
[TBL] [Abstract][Full Text] [Related]
9. Differentiation: an encouraging approach to anticancer therapy.
Marchal JA; Rodríguez-Serrano F; Campos J; Madeddu R; Boulaiz H; Martínez-Amat A; Carrillo E; Caba O; Prados JC; Vélez C; Melguizo C; Montella A; Aránega A
Ital J Anat Embryol; 2006; 111(1):45-64. PubMed ID: 16736717
[TBL] [Abstract][Full Text] [Related]
10. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I; Shamsuddin AM
Anticancer Res; 1998; 18(6A):4083-90. PubMed ID: 9891449
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene.
Xu HM; Tepper CG; Jones JB; Fernandez CE; Studzinski GP
Exp Cell Res; 1993 Dec; 209(2):367-74. PubMed ID: 8262155
[TBL] [Abstract][Full Text] [Related]
12. p53 and response to chemotherapy and radiotherapy.
Ruley HE
Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
[No Abstract] [Full Text] [Related]
13. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
Felsher DW
Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells: a step toward the cure.
Boman BM; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
[No Abstract] [Full Text] [Related]
15. Applications of antisense oligonucleotides in oncology.
Pierga JY; Magdelenat H
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
[TBL] [Abstract][Full Text] [Related]
16. An experimental model for oncogene activation during tumor progression in vivo.
Garte SJ; Burns FJ; Ashkenazi-Kimmel T; Cosma GN; Sawey MJ
Anticancer Res; 1989; 9(5):1439-46. PubMed ID: 2686538
[TBL] [Abstract][Full Text] [Related]
17. Molecular interrelationships in multidrug resistance (review).
Kellen JA
Anticancer Res; 1994; 14(2A):433-5. PubMed ID: 8017843
[TBL] [Abstract][Full Text] [Related]
18. A stochastic model of oncogene expression and the relevance of this model to cancer therapy.
Alfano FD
Theor Biol Med Model; 2006 Jan; 3():5. PubMed ID: 16448558
[TBL] [Abstract][Full Text] [Related]
19. The HL60 cell line: a model system for studying human myeloid cell differentiation.
Birnie GD
Br J Cancer Suppl; 1988 Dec; 9():41-5. PubMed ID: 3076064
[TBL] [Abstract][Full Text] [Related]
20. Resistance to neoplastic transformation induced by nonterminal differentiation.
Estervig DN; Maercklein PB; Scott RE
Cancer Res; 1989 Feb; 49(4):1008-13. PubMed ID: 2912546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
